The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comprehensive genomic and immune profiling defines immunotherapy treatment in patients with NSCLC with low PD-L1 IHC.
 
Sarabjot Pabla
Employment - Omniseq
Patents, Royalties, Other Intellectual Property - Patent pending at Omniseq (Inst)
 
Robert J. Seager
Employment - Omniseq
 
Mary Nesline
Employment - Omniseq
Stock and Other Ownership Interests - Omniseq
 
Paul DePietro
Employment - Omniseq
Stock and Other Ownership Interests - Omniseq
 
Erik Van Roey
Employment - Omniseq
 
Shuang Gao
Employment - Omniseq
 
Shakti Ramkissoon
Employment - Foundation Medicine; LabCorp
Stock and Other Ownership Interests - Foundation Medicine
 
Lei Deng
No Relationships to Disclose
 
Shengle Zhang
Employment - Omniseq
 
Roger David Klein
Employment - OmniSeq
Leadership - OmniSeq
Stock and Other Ownership Interests - Illumina; Merck; Novartis; OmniSeq; Pacific Biosciences; Sarepta Therapeutics
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Abbott Laboratories; AstraZeneca; Molecular Health; Novartis
Research Funding - Qiagen (Inst)
Expert Testimony - Wilson Sonsini
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; Illumina; Novartis; Roche
 
Jeffrey M. Conroy
Employment - Omniseq
Leadership - OmniSeq
Stock and Other Ownership Interests - Omniseq
Patents, Royalties, Other Intellectual Property - Omniseq